| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Minireview |
Department of Medical Oncology, Vrije Universiteit Medical Center, HV 1081 Amsterdam, the Netherlands
Recent knowledge on apoptosis has made it possible to devise novel approaches, which exploit this process to treat cancer. In this review, we discuss in detail approaches to induce tumor cell apoptosis, their mechanism of action, stage of development, and possible drawbacks. Finally, the obstacles yet to be overcome and the perspectives for potential clinical use of apoptosis-triggering approaches in cancer therapy in the future are assessed.
This article has been cited by other articles:
|
|
 |
|
  X. ZHANG, E. VARIN, M. BRIAND, S. ALLOUCHE, N. HEUTTE, L. SCHWARTZ, L. POULAIN, and P. ICARD Novel Therapy for Malignant Pleural Mesothelioma Based on Anti-energetic Effect: An Experimental Study Using 3-Bromopyruvate on Nude Mice Anticancer Res, April 1, 2009; 29(4): 1443 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Maksimovic-Ivanic, S. Mijatovic, L. Harhaji, D. Miljkovic, D. Dabideen, K. Fan Cheng, K. Mangano, G. Malaponte, Y. Al-Abed, M. Libra, et al. Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo Mol. Cancer Ther., March 1, 2008; 7(3): 510 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Lee, E. J. Kim, S. Kim, E. M. Jung, J.-W. Park, S. H. Jeong, S. E. Park, Y. H. Yoo, and T. K. Kwon Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol. Cancer Ther., September 1, 2006; 5(9): 2398 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Yang, T.-C. Hsia, H.-M. Kuo, P.-D. L. Chao, C.-C. Chou, Y.-H. Wei, and J.-G. Chung INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G2/M ARREST AND INDUCTION OF APOPTOSIS Drug Metab. Dispos., February 1, 2006; 34(2): 296 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Westfall and M. K. Skinner Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment Mol. Cancer Ther., November 1, 2005; 4(11): 1764 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, R. M. Cheung, R. Komaki, B. Fang, and J. Y. Chang Radiotherapy Sensitization by Tumor-Specific TRAIL Gene Targeting Improves Survival of Mice Bearing Human Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2005; 11(18): 6657 - 6668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ceruti, A. Mazzola, and M. P. Abbracchio Resistance of Human Astrocytoma Cells to Apoptosis Induced by Mitochondria-Damaging Agents: Possible Implications for Anticancer Therapy J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 825 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Ghobrial, T. E. Witzig, and A. A. Adjei Targeting Apoptosis Pathways in Cancer Therapy CA Cancer J Clin, May 1, 2005; 55(3): 178 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Gillespie, X. D. Zhang, and P. Hersey Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells Mol. Cancer Ther., December 1, 2004; 3(12): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Adhami, M. H. Aziz, S. R. Reagan-Shaw, M. Nihal, H. Mukhtar, and N. Ahmad Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery Mol. Cancer Ther., August 1, 2004; 3(8): 933 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Herbst and S. R. Frankel Oblimersen Sodium (Genasense bcl-2 Antisense Oligonucleotide): A Rational Therapeutic to Enhance Apoptosis in Therapy of Lung Cancer Clin. Cancer Res., June 15, 2004; 10(12): 4245S - 4248S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Jazirehi and B. Bonavida Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol. Cancer Ther., January 1, 2004; 3(1): 71 - 84. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Filomeni, K. Aquilano, G. Rotilio, and M. R. Ciriolo Reactive Oxygen Species-dependent c-Jun NH2-terminal Kinase/c-Jun Signaling Cascade Mediates Neuroblastoma Cell Death Induced by Diallyl Disulfide Cancer Res., September 15, 2003; 63(18): 5940 - 5949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Padanilam Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis Am J Physiol Renal Physiol, April 1, 2003; 284(4): F608 - F627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. E. de Vries, M. N. de Hooge, J. A. Gietema, and S. de Jong Correspondence re: C. G. Ferreira et al., Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024-2034, 2002. Clin. Cancer Res., February 1, 2003; 9(2): 912 - 912. [Full Text] [PDF]
|
|
|
|
|
|
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone Reply Clin. Cancer Res., February 1, 2003; 9(2): 913 - 914. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
